Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets

Por Ruppe, Mary D, Brosnan, Patrick G, Au, Kit Sing, Tran, Phong X, Dominguez, Barbara W, Northrup, Hope
Publicado em 2011

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

Por Carpenter, Thomas O., Imel, Erik A., Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Wooddell, Margaret M., Kawakami, Tetsuyoshi, Ito, Takahiro, Zhang, Xiaoping, Humphrey, Jeffrey, Insogna, Karl L., Peacock, Munro
Publicado em 2014

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23

Por Imel, Erik A., Zhang, Xiaoping, Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey S., Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Peacock, Munro, Carpenter, Thomas O.
Publicado no J Clin Endocrinol Metab (2015)

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia

Por Ruppe, Mary D., Zhang, Xiaoping, Imel, Erik A., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey S., Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Peacock, Munro, Carpenter, Thomas O.
Publicado no Bone Rep (2016)

Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia...

Por Zhang, Xiaoping, Imel, Erik A., Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey, Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Carpenter, Thomas O., Peacock, Munro
Publicado no J Clin Pharmacol (2015)